title: Long term telemedicine study of compliance in paranoid schizophrenia.
abstract: BACKGROUND
  Low compliance is one of the crucial problems of contemporary psychiatry. Relapses, deterioration of cognitive functioning, negative symptoms, neuroleptic resistance are the examples of many consequences of noncompliance in schizophrenia
  
  
  METHODS
  The study was designed to assess the compliance in the 200 patients diagnosed with paranoid schizophrenia, all in the state of symptomatic remission and on the stable neuroleptic treatment. The compliance was assessed using a telepsychiatric system, sending reminders: 1 hour before the planned dose to remind them that drug intake is approaching, and at the moment of intake to check if they took the drug. The confirmed drug intakes were counted by the telepsychiatric system.
  
  
  RESULTS
  158 patients completed the study period. The compliance in the first month of the treatment was 44.6% and decreased over the rest of the period to the level of 33.4%. 50% of the schizophrenic patients were compliant at a level lower than 37%. This group was considered the low compliance group, and in this group the compliance increased after 6 months from 9.3% to 10.3% (p<0.0001).
  
  
  CONCLUSIONS
  The compliance in the group of schizophrenic patients in remission is very low. The telemedicine system improves the compliance in the patients with the worst compliance.
authors.affiliation: Department of Rehabilitation Psychiatry, Medical School of Silesia, Ziołowa 45 Street, 40-635 Katowice, Poland, krzystanekmarek@gmail.com.
authors.forename: Marek
authors.initials: M
authors.lastname: Krzystanek
authors.forename: Dariusz
authors.initials: D
authors.lastname: Krzeszowski
authors.forename: Karolina
authors.initials: K
authors.lastname: Jagoda
authors.forename: Krzysztof
authors.initials: K
authors.lastname: Krysta
mesh_terms: D000328:Adult; D014150:Antipsychotic Agents / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008137:Longitudinal Studies; D008297:Male; D055118:Medication Adherence / Q000523:psychology*; D012008:Recurrence; D017010:Reminder Systems; D012563:Schizophrenia, Paranoid / Q000188:drug therapy* / Q000523:psychology; D000068997:Smartphone; D017216:Telemedicine
chemical_list: D014150:Antipsychotic Agents